Infectious diseases occurring in the context of substance use disorders: A concise review.


Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 Apr 2020
Historique:
received: 15 07 2019
revised: 13 01 2020
accepted: 29 01 2020
pubmed: 20 2 2020
medline: 15 5 2021
entrez: 20 2 2020
Statut: ppublish

Résumé

Prevalence of infectious diseases is substantially higher among patients with substance use disorders (SUD). Factors associated with drug use including sharing needles and injecting supplies, presence of contaminants in drugs and drug use related paraphernalia, risky behaviors associated with drug use, immune suppression secondary to chronic drug use, poverty and homelessness all increase the risk of infections. Persons with SUD have low rates of health care utilization and may miss opportunities for early diagnosis and care of infectious complications of substance use. When infectious diseases are comorbid with drug use, they are associated with substantial morbidity and mortality and result in significant healthcare costs. Patients with SUD may be rescued from an overdose, detoxified or treated for a SUD but facilities and clinicians are often reluctant to assume responsibility for evaluation and treatment of concurrent infectious or medical diseases. Increased screening for these disorders, utilizing vaccinations and other preventative strategies including clean supplies and safe injecting sites and providing comprehensive substance use and infectious disease treatment have the potential to significantly improve patient related outcomes and enhance public health. In this paper we review the prevalence of various common infectious diseases among persons who use drugs, their clinical presentation, mode of transmission, screening and diagnosis. We detail some of the common mechanisms by which persons who use drugs are at increased risk of contracting infections. We also discuss preventive and treatment strategies for infectious diseases occurring in the context of SUD.

Identifiants

pubmed: 32070807
pii: S0022-510X(20)30055-1
doi: 10.1016/j.jns.2020.116719
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

116719

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Bhanu Prakash Kolla (BP)

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, United States of America. Electronic address: kolla.bhanuprakash@mayo.edu.

Tyler Oesterle (T)

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, United States of America.

Mark Gold (M)

Washington University in St Louis, School of Medicine, St Louis, MO, United States of America.

Frederick Southwick (F)

Department of Medicine, University of Florida, Gainesville, FL, United States of America.

Teresa Rummans (T)

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH